Aβ oligomers induce neuronal cell cycle events in Alzheimer's disease

Nicholas H. Varvel, Kiran Bhaskar, Anita R. Patil, Sanjay W. Pimplikar, Karl Herrup, Bruce Lamb

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Neurons subject to degeneration in Alzheimer's disease (AD) exhibit evidence of re-entry into a mitotic cell cycle even before the development of substantial AD brain pathology. In efforts to identify the initiating factors underlying these cell cycle events (CCEs), we have characterized the appearance of the neuronal CCEs in the genomic-based R1.40 transgenic mouse model of AD. Notably, R1.40 mice exhibit neuronal CCEs in a reproducible temporal and spatial pattern that recapitulates the neuronal vulnerability seen in human AD. Neuronal CCEs first appear at 6 months in the frontal cortex layers II/III. This is 6-8 months before detectable amyloid β (Aβ) deposition, suggesting that specific amyloid precursor protein (APP) processing products are responsible for the induction of neuronal CCEs. Furthermore, a reduction in the levels of Aβ (achieved by shifting the genetic background from C57BL/6 to the DBA/2 mouse strain) dramatically delays the appearance of neuronal CCEs. More significantly, elimination of β-secretase activity blocks the appearance of CCEs, providing direct genetic evidence that the amyloidogenic processing of APP is required for the induction of CCEs. Finally, in vitro preparations of oligomeric, but not monomeric, Aβ induce DNA synthesis in dissociated cortical neurons, and this response is blocked by antioligomer specific antibodies. Together, our data suggest that low molecular weight aggregates of Aβ induce neuronal cell cycle re-entry in mouse models of Alzheimer's disease.

Original languageEnglish (US)
Pages (from-to)10786-10793
Number of pages8
JournalJournal of Neuroscience
Volume28
Issue number43
DOIs
StatePublished - Oct 22 2008
Externally publishedYes

Fingerprint

Cell Cycle
Alzheimer Disease
Amyloid beta-Protein Precursor
Neurons
Amyloid Precursor Protein Secretases
Inbred DBA Mouse
Frontal Lobe
Amyloid
Transgenic Mice
Molecular Weight
Pathology
Antibodies
DNA
Brain

Keywords

  • β-amyloid
  • Alzheimer's disease
  • APP
  • Cyclin A
  • Neuronal cell cycle
  • Transgenic mice

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)

Cite this

Varvel, N. H., Bhaskar, K., Patil, A. R., Pimplikar, S. W., Herrup, K., & Lamb, B. (2008). Aβ oligomers induce neuronal cell cycle events in Alzheimer's disease. Journal of Neuroscience, 28(43), 10786-10793. https://doi.org/10.1523/JNEUROSCI.2441-08.2008

Aβ oligomers induce neuronal cell cycle events in Alzheimer's disease. / Varvel, Nicholas H.; Bhaskar, Kiran; Patil, Anita R.; Pimplikar, Sanjay W.; Herrup, Karl; Lamb, Bruce.

In: Journal of Neuroscience, Vol. 28, No. 43, 22.10.2008, p. 10786-10793.

Research output: Contribution to journalArticle

Varvel, NH, Bhaskar, K, Patil, AR, Pimplikar, SW, Herrup, K & Lamb, B 2008, 'Aβ oligomers induce neuronal cell cycle events in Alzheimer's disease', Journal of Neuroscience, vol. 28, no. 43, pp. 10786-10793. https://doi.org/10.1523/JNEUROSCI.2441-08.2008
Varvel, Nicholas H. ; Bhaskar, Kiran ; Patil, Anita R. ; Pimplikar, Sanjay W. ; Herrup, Karl ; Lamb, Bruce. / Aβ oligomers induce neuronal cell cycle events in Alzheimer's disease. In: Journal of Neuroscience. 2008 ; Vol. 28, No. 43. pp. 10786-10793.
@article{718a966c6a95469ca7bedd9a43459960,
title = "Aβ oligomers induce neuronal cell cycle events in Alzheimer's disease",
abstract = "Neurons subject to degeneration in Alzheimer's disease (AD) exhibit evidence of re-entry into a mitotic cell cycle even before the development of substantial AD brain pathology. In efforts to identify the initiating factors underlying these cell cycle events (CCEs), we have characterized the appearance of the neuronal CCEs in the genomic-based R1.40 transgenic mouse model of AD. Notably, R1.40 mice exhibit neuronal CCEs in a reproducible temporal and spatial pattern that recapitulates the neuronal vulnerability seen in human AD. Neuronal CCEs first appear at 6 months in the frontal cortex layers II/III. This is 6-8 months before detectable amyloid β (Aβ) deposition, suggesting that specific amyloid precursor protein (APP) processing products are responsible for the induction of neuronal CCEs. Furthermore, a reduction in the levels of Aβ (achieved by shifting the genetic background from C57BL/6 to the DBA/2 mouse strain) dramatically delays the appearance of neuronal CCEs. More significantly, elimination of β-secretase activity blocks the appearance of CCEs, providing direct genetic evidence that the amyloidogenic processing of APP is required for the induction of CCEs. Finally, in vitro preparations of oligomeric, but not monomeric, Aβ induce DNA synthesis in dissociated cortical neurons, and this response is blocked by antioligomer specific antibodies. Together, our data suggest that low molecular weight aggregates of Aβ induce neuronal cell cycle re-entry in mouse models of Alzheimer's disease.",
keywords = "β-amyloid, Alzheimer's disease, APP, Cyclin A, Neuronal cell cycle, Transgenic mice",
author = "Varvel, {Nicholas H.} and Kiran Bhaskar and Patil, {Anita R.} and Pimplikar, {Sanjay W.} and Karl Herrup and Bruce Lamb",
year = "2008",
month = "10",
day = "22",
doi = "10.1523/JNEUROSCI.2441-08.2008",
language = "English (US)",
volume = "28",
pages = "10786--10793",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "43",

}

TY - JOUR

T1 - Aβ oligomers induce neuronal cell cycle events in Alzheimer's disease

AU - Varvel, Nicholas H.

AU - Bhaskar, Kiran

AU - Patil, Anita R.

AU - Pimplikar, Sanjay W.

AU - Herrup, Karl

AU - Lamb, Bruce

PY - 2008/10/22

Y1 - 2008/10/22

N2 - Neurons subject to degeneration in Alzheimer's disease (AD) exhibit evidence of re-entry into a mitotic cell cycle even before the development of substantial AD brain pathology. In efforts to identify the initiating factors underlying these cell cycle events (CCEs), we have characterized the appearance of the neuronal CCEs in the genomic-based R1.40 transgenic mouse model of AD. Notably, R1.40 mice exhibit neuronal CCEs in a reproducible temporal and spatial pattern that recapitulates the neuronal vulnerability seen in human AD. Neuronal CCEs first appear at 6 months in the frontal cortex layers II/III. This is 6-8 months before detectable amyloid β (Aβ) deposition, suggesting that specific amyloid precursor protein (APP) processing products are responsible for the induction of neuronal CCEs. Furthermore, a reduction in the levels of Aβ (achieved by shifting the genetic background from C57BL/6 to the DBA/2 mouse strain) dramatically delays the appearance of neuronal CCEs. More significantly, elimination of β-secretase activity blocks the appearance of CCEs, providing direct genetic evidence that the amyloidogenic processing of APP is required for the induction of CCEs. Finally, in vitro preparations of oligomeric, but not monomeric, Aβ induce DNA synthesis in dissociated cortical neurons, and this response is blocked by antioligomer specific antibodies. Together, our data suggest that low molecular weight aggregates of Aβ induce neuronal cell cycle re-entry in mouse models of Alzheimer's disease.

AB - Neurons subject to degeneration in Alzheimer's disease (AD) exhibit evidence of re-entry into a mitotic cell cycle even before the development of substantial AD brain pathology. In efforts to identify the initiating factors underlying these cell cycle events (CCEs), we have characterized the appearance of the neuronal CCEs in the genomic-based R1.40 transgenic mouse model of AD. Notably, R1.40 mice exhibit neuronal CCEs in a reproducible temporal and spatial pattern that recapitulates the neuronal vulnerability seen in human AD. Neuronal CCEs first appear at 6 months in the frontal cortex layers II/III. This is 6-8 months before detectable amyloid β (Aβ) deposition, suggesting that specific amyloid precursor protein (APP) processing products are responsible for the induction of neuronal CCEs. Furthermore, a reduction in the levels of Aβ (achieved by shifting the genetic background from C57BL/6 to the DBA/2 mouse strain) dramatically delays the appearance of neuronal CCEs. More significantly, elimination of β-secretase activity blocks the appearance of CCEs, providing direct genetic evidence that the amyloidogenic processing of APP is required for the induction of CCEs. Finally, in vitro preparations of oligomeric, but not monomeric, Aβ induce DNA synthesis in dissociated cortical neurons, and this response is blocked by antioligomer specific antibodies. Together, our data suggest that low molecular weight aggregates of Aβ induce neuronal cell cycle re-entry in mouse models of Alzheimer's disease.

KW - β-amyloid

KW - Alzheimer's disease

KW - APP

KW - Cyclin A

KW - Neuronal cell cycle

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=58149151433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149151433&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.2441-08.2008

DO - 10.1523/JNEUROSCI.2441-08.2008

M3 - Article

VL - 28

SP - 10786

EP - 10793

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 43

ER -